These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9890694)

  • 1. Economic evaluation of cancer treatments: methodological and practical issues.
    Uyl-de Groot CA; Touw CR
    Anticancer Drugs; 1998 Nov; 9(10):835-41. PubMed ID: 9890694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodology of economic assessment: example in oncology].
    Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
    Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation alongside cancer trials: methodological and practical aspects.
    Bonsel GJ; Rutten FF; Uyl-de Groot CA
    Eur J Cancer; 1993; 29A Suppl 7():S10-4. PubMed ID: 8312059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation in support of national health policy: the case of The Netherlands.
    Elsinga E; Rutten FF
    Soc Sci Med; 1997 Aug; 45(4):605-20. PubMed ID: 9226785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dollar is a dollar is a dollar--or is it?
    Brouwer WB; van Exel NJ; Baltussen RM; Rutten FF
    Value Health; 2006; 9(5):341-7. PubMed ID: 16961552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and economic evaluation in schizophrenia: implications for health policies.
    Moscarelli M
    Acta Psychiatr Scand Suppl; 1994; 382():84-8. PubMed ID: 8092004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes.
    Drummond M; O'Brien B
    Health Econ; 1993 Oct; 2(3):205-12. PubMed ID: 8275165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health services research clinical trials: issues in the evaluation of economic costs and benefits.
    Manheim LM
    Control Clin Trials; 1998 Apr; 19(2):149-58. PubMed ID: 9551279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of health care and policymaking.
    Johannesson M
    Health Policy; 1995 Sep; 33(3):179-90. PubMed ID: 10145120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of treatments for cancer in childhood.
    Barr RD; Feeny D; Furlong W
    Eur J Cancer; 2004 Jun; 40(9):1335-45. PubMed ID: 15177493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making cost assessments based on RCTs more useful to decision-makers.
    Baltussen R; Ament A; Leidl R
    Health Policy; 1996 Sep; 37(3):163-83. PubMed ID: 10160021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering affordable cancer care in high-income countries.
    Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
    Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes measurement: health state preferences and economic evaluation.
    Oldridge NB
    Assist Technol; 1996; 8(2):94-102. PubMed ID: 10163933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.